Asystole during dipyridamole infusion in patients without coronary artery disease or beta-blocker therapy

Clinical Nuclear Medicine

Volumn 22, Issue 2, 1997, Pages 97-100

  Frossard, Martin ^b   Weiss, Konrad ^b   Gössinger, Heinz ^b   Zeiner, Andrea ^b   Leith, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE; THALLIUM 201;

ADULT; ANGINA PECTORIS; ARTICLE; ASYSTOLE; BRADYCARDIA; CASE REPORT; CORONARY ARTERY DISEASE; EXERCISE TEST; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; NAUSEA; VERTIGO;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; AUTONOMIC NERVOUS SYSTEM DISEASES; BRADYCARDIA; CORONARY CIRCULATION; CORONARY DISEASE; DIPYRIDAMOLE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FOLLOW-UP STUDIES; HEART; HEART ARREST; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; VASODILATOR AGENTS;

EID: 0031035931     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199702000-00005     Document Type: Article

References (16)

1. Josephson MA, Brown GB, Hecht HS, et al: Non-invasive detection and localization of coronary stenosis in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging. Am Heart J 103:1008, 1982
2. Albro DL: Non-invasive assessment of coronary stenosis by myocardial imaging during pharmacologic coronary vasodilatation. III Clinical trial Am J Cardiol 42:751, 1978
3. Wilcken DEL, Paoloni HJ, Eikens E: Evidence for intravenous dipyridamole (Persantin) producing a "coronary steal" effect in the ischemic myocardium. Aust N Z J Med 1:8, 1971.
4. Ranhosky A, Kempthorne-Rawson J: The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 81:1205, 1990.
5. Homma S, Gilliland Y, Guiney TE, et al: Safety of intravenous dipyridamole for stress testing with thallium imaging. Am J Cardiol 59:152, 1987
6. Laarman GJ, Niemeyer MG, van der Wall EE, et al: Dipyridamole thallium testing: noncardiac side effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise. Int J Cardiol 20:231, 1988
7. Leitha T, Gwechenberger M, Falger-Banyai S: Does Dyspnoea during dipyridamole cardiac stress testing indicate broncho- spasm and is the pretest clinical history predictive of this side-effect? Eur J Nucl Med 22:1408, 1995.
8. Pirelli S, Inglese E, Suppa M, et al: Dipyridamole thallium-201 scintigraphy in the early postinfarction period: safety and accuracy in predicting the extent of coronary disease and future recurrence of angina in patients suffering from their first myocardial infarction, Eur Heart J 9:1324, 1988.
9. Pennell DJ, Underwood SR, Ell PJ: Symptomatic bradycardia complicating the use of intravenous dipyridamole for thallium201 myocardial perfusion imaging. Int J Cardiol 27:272, 1990.
10. Blumenthal MS, McCauley CS: Cardiac arrest during dipyridamole imaging. Chest 93:1103, 1988.
11. Roach PJ, Magee MA, Freedman SB: Asystole and bradyeardia during dipyridamole stress testing in patients receiving beta-blockers. Int J Cardiol 42:92, 1993.
12. Mauro RL, Sabella FP, Enia F: Sinus arrest associated with dipyridamole infusion. Chest 105:604, 1994.
13. Bubinski R, Markiewicz K, Cholewa M, et al: Electrophysiologic effects of intravenous dipyridamole, Int J Cardiol 24:327, 1989.
14. Biaggioni I, onrot J, Hollister A, et al: Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole. Life Sci 39:2229, 1986.
15. Lerman BB, Belardinelli L: Cardiac electrophysiology of adenosine. Circulation 83:1499, 1991.
16. Camm AJ, Garratt CJ: Adenosine and supraventricular tachycardia. N Engl J Med 325:1621, 1991.